22 insiders have filed at NVCR since 2023Q3: names, roles, reported stakes, and each person's buying and selling record from SEC Form 3/4/5 filings.
| name | role | reported stake | % of company | buys (3y) | sells (3y) |
|---|---|---|---|---|---|
| Leonard Frank X | Chief Executive Officer | 493.8k | 0.433% | 14 sells $1.3M | |
| Cordova Ashley | Former Chief Executive Officer | 422.6k | 0.37% | 1 buys $997k | 7 sells $372k |
| Danziger Asaf | Director | 416.5k | 0.365% | ||
| Doyle William F | Executive Chairman | 328.4k | 0.288% | 2 sells $933k | |
| Weinberg Uri | Chf Medical And Innovation Ofr | 267.2k | 0.234% | 6 sells $324k | |
| Groenhuysen Wilhelmus Cm | Chief Operating Officer | 252.3k | 0.221% | 4 sells $97k | |
| Ben Arye Barak | General Counsel | 242.5k | 0.212% | ||
| Puri Michal Nath | Chief Human Resources Officer | 201.3k | 0.176% | 5 sells $75k | |
| Brackmann Christoph | Chief Financial Officer | 182.8k | 0.16% | 3 buys $232k | 1 sells $85k |
| Vernon W Anthony | Director | 179.1k | 0.157% | 2 sells $40k | |
| Shah Pritesh | Chief Growth Officer | 124.5k | 0.109% | 2 sells $11k | |
| Leupin Nicolas | Former Chief Medical Officer | 103.0k | 0.09% | 4 sells $49k | |
| Leung Gabriel | Director | 92.4k | 0.081% | 2 sells $40k | |
| Paravasthu Mukund | Chief Operating Officer | 72.8k | 0.064% | 12 sells $810k | |
| Giladi Moshe | Chief Science Officer | 69.8k | 0.061% | ||
| Burke William Patrick | Chief Human Resources Officer | 66.4k | 0.058% | ||
| Hung David | Director | 23.4k | 0.021% | 1 sells $17k | |
| Madden Martin J. | Director | 18.7k | 0.016% | 1 sells $17k | |
| Scannell Timothy J | Director | 17.2k | 0.015% | 2 sells $40k | |
| Hilleman Jeryl L | Director | 16.8k | 0.015% | 1 sells $17k | |
| Ocean Allyson J | Director | 14.3k | 0.013% | 1 sells $17k | |
| Stafford Kristin | Director | 14.3k | 0.013% | 1 sells $17k |
Full register at boothcheck.com/insiders/NVCR. Stakes are the newest reported Form 3/4/5 balances (they update only when insiders file). Sales counted include pre-scheduled plan sales, labeled. A filed record, not a forecast. Nothing here is investment advice.